Effects of chronotropic incompetence on exercise capacity in people with heart failure versus age-matched controls

Smart Na1, Clark H2, Brubaker P3

  • 1Department, of Clinical Exercise Physiology, School of Science and Technology, University of New England, Armidale, NSW, 2351, Australia. n_smart@hotmail.com.

Heart Failure Reviews
|April 19, 2021
PubMed

Insights

Chronotropic incompetence (CI) is common in heart failure patients, affecting over 50% of those with reduced or preserved ejection fraction. This condition is linked to reduced exercise capacity and increased mortality in heart failure with reduced ejection fraction.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Chronotropic incompetence (CI) is defined as an inability to adequately increase heart rate during physiological stress.
  • Prevalence and impact of CI on exercise capacity in heart failure (HF) are not fully understood.

Purpose of the Study:

  • To determine the prevalence of CI in patients with heart failure with reduced (HFrEF) and preserved (HFpEF) ejection fraction compared to healthy controls.
  • To assess the association between CI and exercise capacity (peak VO2) and mortality in HF patients.

Main Methods:

  • Systematic literature search and meta-analysis of studies published from 1966 to July 2020.
  • Included 17 studies with 4410 participants (4167 with HF, 243 controls).
  • Analyzed peak VO2, maximum heart rate, and mortality data.

Main Results:

  • CI prevalence was significantly higher in HFrEF (51.7%) and HFpEF (55.8%) than in controls (9%).
  • CI was associated with lower peak VO2 (MD -3.30 ml kg-1 min-1) and higher mortality (OR -1.24) in HFrEF.
  • CI was not significantly associated with lower peak VO2 in HFpEF, and respiratory exchange ratios suggested adequate effort.

Conclusions:

  • CI is highly prevalent in both HFrEF and HFpEF patients.
  • CI is linked to reduced exercise capacity and increased mortality in HFrEF.
  • CI's impact on exercise capacity differs between HFrEF and HFpEF, with effort unlikely to be the sole explanation.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
189
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
154
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
912